AstraZeneca Aktie
122,25
EUR
+1,50
EUR
+1,24
%
103,96
GBP
+0,04
GBP
+0,04
%
Werbung
AstraZeneca Aktie Analyse
03.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
02.04.19 | AstraZeneca Sell | UBS AG | |
02.04.19 | AstraZeneca Reduce | HSBC | |
01.04.19 | AstraZeneca overweight | Barclays Capital | |
01.04.19 | AstraZeneca Neutral | UBS AG | |
01.04.19 | AstraZeneca buy | Deutsche Bank AG | |
29.03.19 | AstraZeneca Outperform | Credit Suisse Group | |
29.03.19 | AstraZeneca overweight | Barclays Capital | |
Werbung
|
|||
29.03.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
29.03.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
12.03.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
05.03.19 | AstraZeneca buy | Deutsche Bank AG | |
28.02.19 | AstraZeneca Reduce | HSBC | |
26.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
26.02.19 | AstraZeneca buy | Deutsche Bank AG | |
26.02.19 | AstraZeneca overweight | Barclays Capital | |
25.02.19 | AstraZeneca overweight | Barclays Capital | |
18.02.19 | AstraZeneca buy | Deutsche Bank AG | |
15.02.19 | AstraZeneca Outperform | Credit Suisse Group | |
14.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
14.02.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
14.02.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
29.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
22.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
14.01.19 | AstraZeneca buy | Deutsche Bank AG | |
02.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
20.12.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
14.12.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
14.12.18 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
11.12.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
07.12.18 | AstraZeneca Outperform | Credit Suisse Group | |
28.11.18 | AstraZeneca Reduce | HSBC | |
19.11.18 | AstraZeneca Neutral | UBS AG | |
19.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
16.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
16.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
13.11.18 | AstraZeneca buy | Deutsche Bank AG | |
12.11.18 | AstraZeneca Reduce | HSBC | |
12.11.18 | AstraZeneca buy | Deutsche Bank AG | |
09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
09.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
09.11.18 | AstraZeneca Hold | CFRA | |
09.11.18 | AstraZeneca overweight | Barclays Capital | |
08.11.18 | AstraZeneca Neutral | UBS AG | |
08.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
30.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
22.10.18 | AstraZeneca buy | Deutsche Bank AG | |
19.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
12.10.18 | AstraZeneca Hold | Jefferies & Company Inc. |
Werbung
Werbung